(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are BIOTALYS, PCI BIOTECH HOLD, and OCEANTEAM.

Financial Asset	Price	Change	Updated (EST)
BIOTALYS (BTLS.BR)	3.96	23.75%	2023-12-19 12:05:21
PCI BIOTECH HOLD (PCIB.OL)	2.15	17.49%	2023-12-19 12:42:09
OCEANTEAM (OTS.OL)	1.39	10.8%	2023-12-19 12:41:47
BORGESTAD (BOR.OL)	0.31	10.71%	2023-12-19 12:25:08
VIRBAC (VIRP.PA)	336.50	10.69%	2023-12-19 13:24:42
AFFLUENT MEDICAL (AFME.PA)	1.43	9.16%	2023-12-19 12:45:08
EQVA (EQVA.OL)	3.25	7.26%	2023-12-19 12:25:59
ADOCIA (ADOC.PA)	8.87	7.26%	2023-12-19 12:44:57
PLAST.VAL LOIRE (PVL.PA)	2.90	6.23%	2023-12-19 13:21:34
WORLDLINE (WLN.PA)	16.38	6.09%	2023-12-19 13:24:57

The three biggest losers today are NORTHERN DRILLING, CASINO GUICHARD, and NR21.

Financial Asset	Price	Change	Updated (EST)
NORTHERN DRILLING (NODL.OL)	1.46	-23.82%	2023-12-19 12:41:36
CASINO GUICHARD (CO.PA)	0.69	-11.88%	2023-12-19 13:00:58
NR21 (NR21.PA)	54.00	-10%	2023-12-19 13:20:47
ATLANTIC SAPPHIRE (ASA.OL)	1.83	-9.85%	2023-12-19 12:24:44
FIPP (FIPP.PA)	0.12	-8.66%	2023-12-19 13:03:45
MKB Nedsense (NEDSE.AS)	0.09	-7.84%	2023-12-19 12:02:57
IEX GROUP NV (IEX.AS)	1.70	-7.61%	2023-12-19 12:02:35
GLINTT (GLINT.LS)	0.35	-5.85%	2023-12-19 12:23:15
CRCAM ILLE-VIL.CCI (CIV.PA)	56.02	-5.37%	2023-12-19 13:01:42
FERMENTALG (FALG.PA)	0.25	-4.94%	2023-12-19 13:03:28

Winners today

1. BIOTALYS (BTLS.BR)

23.75% Price Change

Biotalys NV, an agricultural technology company, discovers and develops novel biological products for the protection of food and crops. It primarily develops biofungicides, bioinsecticides, and biobactericides. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.

BEL 20 ended the session with BIOTALYS jumping 23.75% to €3.96 on Tuesday while BEL 20 jumped 0.6% to €3,742.59.

Earnings Per Share

As for profitability, BIOTALYS has a trailing twelve months EPS of €-0.76.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BIOTALYS’s stock is considered to be overbought (>=80).

Volatility

BIOTALYS’s last week, last month’s, and last quarter’s current intraday variation average was 0.24%, 1.70%, and 5.19%.

BIOTALYS’s highest amplitude of average volatility was 1.18% (last week), 9.50% (last month), and 5.19% (last quarter).

Volume

Today’s last reported volume for BIOTALYS is 110430 which is 186.78% above its average volume of 38506.

More news about BIOTALYS.

2. PCI BIOTECH HOLD (PCIB.OL)

17.49% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD rising 17.49% to €2.15 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.72% to €1,299.63.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.79.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.54%.

Moving Average

PCI BIOTECH HOLD’s value is under its 50-day moving average of kr2.17 and higher than its 200-day moving average of kr1.97.

More news about PCI BIOTECH HOLD.

3. OCEANTEAM (OTS.OL)

10.8% Price Change

Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable turntable systems, and other cable handling and storage equipment, as well as offers cable and umbilical storage, and handling solutions. It serves renewable energy, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM jumping 10.8% to €1.39 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI slid 0.72% to €1,299.63, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.31.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.62%.

More news about OCEANTEAM.

4. BORGESTAD (BOR.OL)

10.71% Price Change

Borgestad ASA develops, manufactures, distributes, and installs refractory products in Norway. The company also develops and manages real estate properties. Its properties include Agora Bytom, a shopping center with a gross area of 52,000 square meters and a rental area of approximately 30,000 square meters, as well as a parking garage with 820 parking lots in Poland. Borgestad ASA was founded in 1904 and is headquartered in Skien, Norway.

Oslo Børs Benchmark Index_GI ended the session with BORGESTAD jumping 10.71% to €0.31 on Tuesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI slid 0.72% to €1,299.63, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, BORGESTAD has a trailing twelve months EPS of kr-0.3.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.11%.

Sales Growth

BORGESTAD’s sales growth is 6.6% for the ongoing quarter and 4% for the next.

Moving Average

BORGESTAD’s value is way under its 50-day moving average of kr1.50 and way under its 200-day moving average of kr1.46.

More news about BORGESTAD.

5. VIRBAC (VIRP.PA)

10.69% Price Change

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

CAC 40 ended the session with VIRBAC rising 10.69% to €336.50 on Tuesday while CAC 40 jumped 0.08% to €7,574.67.

Earnings Per Share

As for profitability, VIRBAC has a trailing twelve months EPS of €14.14.

PE Ratio

VIRBAC has a trailing twelve months price to earnings ratio of 23.8. Meaning, the purchaser of the share is investing €23.8 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.8%.

Volume

Today’s last reported volume for VIRBAC is 9081 which is 63.09% above its average volume of 5568.

More news about VIRBAC.

6. AFFLUENT MEDICAL (AFME.PA)

9.16% Price Change

Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.

CAC 40 ended the session with AFFLUENT MEDICAL jumping 9.16% to €1.43 on Tuesday, after four consecutive sessions in a row of gains. CAC 40 rose 0.08% to €7,574.67, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.65.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.36%.

Volume

Today’s last reported volume for AFFLUENT MEDICAL is 7924 which is 71.32% above its average volume of 4625.

More news about AFFLUENT MEDICAL.

7. EQVA (EQVA.OL)

7.26% Price Change

Eqva ASA, a knowledge-based maritime company, primarily engages in the shipbuilding business worldwide. It operates in two segments, Shipbuilding Technology and Other. The company provides newbuilding, rebuilding, and service assignments on vessels for offshore oil production, renewable energy production, fishing, and fish farming for ship owners. It delivers technology for customers within the seafood, energy, and transport sectors. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was founded in 1999 and is headquartered in Fosnavåg, Norway.

Oslo Børs Benchmark Index_GI ended the session with EQVA rising 7.26% to €3.25 on Tuesday while Oslo Børs Benchmark Index_GI dropped 0.72% to €1,299.63.

Earnings Per Share

As for profitability, EQVA has a trailing twelve months EPS of kr-0.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.45%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EQVA’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth grew by 209.8%, now sitting on 594.65M for the twelve trailing months.

Yearly Top and Bottom Value

EQVA’s stock is valued at kr3.25 at 21:40 EST, way below its 52-week high of kr4.00 and way higher than its 52-week low of kr2.56.

Volatility

EQVA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.62%, a positive 0.36%, and a positive 3.65%.

EQVA’s highest amplitude of average volatility was 6.71% (last week), 4.71% (last month), and 3.65% (last quarter).

More news about EQVA.

8. ADOCIA (ADOC.PA)

7.26% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA jumping 7.26% to €8.87 on Tuesday, following the last session’s downward trend. CAC 40 jumped 0.08% to €7,574.67, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-2.5.

Volume

Today’s last reported volume for ADOCIA is 255207 which is 40.23% above its average volume of 181991.

Revenue Growth

Year-on-year quarterly revenue growth declined by 62.6%, now sitting on 10.84M for the twelve trailing months.

Volatility

ADOCIA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.04%, a negative 0.33%, and a positive 4.45%.

ADOCIA’s highest amplitude of average volatility was 3.10% (last week), 2.87% (last month), and 4.45% (last quarter).

More news about ADOCIA.

9. PLAST.VAL LOIRE (PVL.PA)

6.23% Price Change

Plastiques du Val de Loire engages in the production and sale of plastic parts in France, North America, and internationally. The company offers interior equipment for vehicles, such as cockpits, decoration products, and mechanisms; exterior appearance parts; technical front facades; seat parts; lighting and signaling products; and under the hood parts. It also manufactures plastic products for use in construction and electricity, household electrical appliances, multimedia, leisure and garden, and luxury/design markets. The company was founded in 1963 and is headquartered in Langeais, France.

CAC 40 ended the session with PLAST.VAL LOIRE jumping 6.23% to €2.90 on Tuesday while CAC 40 rose 0.08% to €7,574.67.

Earnings Per Share

As for profitability, PLAST.VAL LOIRE has a trailing twelve months EPS of €-1.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.41%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 24%, now sitting on 785.8M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PLAST.VAL LOIRE’s stock is considered to be oversold (<=20).

Moving Average

PLAST.VAL LOIRE’s value is way higher than its 50-day moving average of €2.58 and below its 200-day moving average of €2.94.

More news about PLAST.VAL LOIRE.

10. WORLDLINE (WLN.PA)

6.09% Price Change

Worldline SA provides payments and transactional services to financial institutions, merchants, corporations, and government agencies in Northern Europe, Central and Eastern Europe, Southern Europe, and internationally. The company operates through Merchant Services; Financial Services; and Mobility & e-Transactional Services segments. The Merchant Services segment offers commercial acquiring, terminal, omnichannel payment acceptance, and digital retail services. The Financial Services segment provides issuing processing, acquiring processing, digital banking, and account payments services. The Mobility & e-Transactional Services segment offers trusted digitization, e-ticketing, and e-consumer and mobility. The company was formerly known as Atos Worldline S.A.S. and changed its name to Worldline SA in April 2014. Worldline SA was founded in 1973 and is headquartered in Puteaux, France.

CAC 40 ended the session with WORLDLINE rising 6.09% to €16.38 on Tuesday while CAC 40 rose 0.08% to €7,574.67.

Earnings Per Share

As for profitability, WORLDLINE has a trailing twelve months EPS of €0.85.

PE Ratio

WORLDLINE has a trailing twelve months price to earnings ratio of 19.26. Meaning, the purchaser of the share is investing €19.26 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.25%.

More news about WORLDLINE.

Losers Today

1. NORTHERN DRILLING (NODL.OL)

-23.82% Price Change

Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING sliding 23.82% to €1.46 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI fell 0.72% to €1,299.63, following the last session’s upward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-5.86.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.

Volatility

NORTHERN DRILLING’s last week, last month’s, and last quarter’s current intraday variation average was a negative 16.65%, a negative 4.26%, and a positive 13.44%.

NORTHERN DRILLING’s highest amplitude of average volatility was 17.00% (last week), 20.24% (last month), and 13.44% (last quarter).

Volume

Today’s last reported volume for NORTHERN DRILLING is 4319680 which is 90.34% above its average volume of 2269350.

Yearly Top and Bottom Value

NORTHERN DRILLING’s stock is valued at kr1.46 at 21:40 EST, way under its 52-week high of kr34.90 and way higher than its 52-week low of kr0.31.

More news about NORTHERN DRILLING.

2. CASINO GUICHARD (CO.PA)

-11.88% Price Change

Casino, Guichard-Perrachon S.A. operates as a food retailer in France, Latin America, and internationally. The company operates hypermarkets, supermarkets, shopping malls, and e-commerce sites, as well as convenience, discount, and cash and carry stores. It also involved in banking, digital marketing, service station, franchise, real estate asset management, property development and trading, rental, banking, and energy-related activities. It operates through stores. The company was founded in 1898 and is based in Saint-Étienne, France.Casino, Guichard-Perrachon S.A operates as a subsidiary of Rallye SA.

CAC 40 ended the session with CASINO GUICHARD sliding 11.88% to €0.69 on Tuesday while CAC 40 rose 0.08% to €7,574.67.

Earnings Per Share

As for profitability, CASINO GUICHARD has a trailing twelve months EPS of €-20.53.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -65.71%.

Volatility

CASINO GUICHARD’s last week, last month’s, and last quarter’s current intraday variation average was a positive 5.40%, a negative 0.32%, and a positive 5.22%.

CASINO GUICHARD’s highest amplitude of average volatility was 5.40% (last week), 6.33% (last month), and 5.22% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CASINO GUICHARD’s stock is considered to be oversold (<=20).

More news about CASINO GUICHARD.

3. NR21 (NR21.PA)

-10% Price Change

NR21 Société Anonyme does not have significant operations. Previously, it was involved in design and distribution of underwear and indoor clothing for men, women, and children. The company is based in Paris, France.

CAC 40 ended the session with NR21 dropping 10% to €54.00 on Tuesday while CAC 40 rose 0.08% to €7,574.67.

Earnings Per Share

As for profitability, NR21 has a trailing twelve months EPS of €0.51.

PE Ratio

NR21 has a trailing twelve months price to earnings ratio of 105.88. Meaning, the purchaser of the share is investing €105.88 for every euro of annual earnings.

Moving Average

NR21’s worth is way below its 50-day moving average of €77.63 and way under its 200-day moving average of €89.35.

More news about NR21.

4. ATLANTIC SAPPHIRE (ASA.OL)

-9.85% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the land-based salmon farming business. It operates through two segments, Fish Farming (Denmark); and Fish Farming (US). The company is involved in the production and sale of salmon. It operates in the United States, Denmark, and internationally. The company was founded in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE falling 9.85% to €1.83 on Tuesday, after five sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI dropped 0.72% to €1,299.63, following the last session’s upward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-5.08.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATLANTIC SAPPHIRE’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

ATLANTIC SAPPHIRE’s stock is valued at kr1.83 at 21:40 EST, way below its 52-week low of kr4.50.

Volume

Today’s last reported volume for ATLANTIC SAPPHIRE is 4860740 which is 180.23% above its average volume of 1734520.

Volatility

ATLANTIC SAPPHIRE’s last week, last month’s, and last quarter’s current intraday variation average was 10.14%, 2.15%, and 3.83%.

ATLANTIC SAPPHIRE’s highest amplitude of average volatility was 10.14% (last week), 4.50% (last month), and 3.83% (last quarter).

More news about ATLANTIC SAPPHIRE.

5. FIPP (FIPP.PA)

-8.66% Price Change

FIPP S.A. is involved in the real estate business in Paris and internationally. The company acquires or constructs buildings for rental. It is also involved in the direct or indirect holding of interests in companies with buildings rental activity. Its property portfolio includes shops and hotels. The company was incorporated in 1920 and is headquartered in Paris, France.

CAC 40 ended the session with FIPP dropping 8.66% to €0.12 on Tuesday, following the last session’s downward trend. CAC 40 rose 0.08% to €7,574.67, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, FIPP has a trailing twelve months EPS of €-0.04.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.74%.

More news about FIPP.

6. MKB Nedsense (NEDSE.AS)

-7.84% Price Change

MKB Nedsense N.V. engages in the finance and lending of money to natural persons and legal entities. It also provides guarantees and/or other securities towards third parties for its obligations and/or for obligations for companies in the investment portfolio. The company was formerly known as Nedsense Enterprises N.V. MKB Nedsense N.V. was founded in 1999 and is based in Bussum, the Netherlands.

AEX-Index ended the session with MKB Nedsense dropping 7.84% to €0.09 on Tuesday while AEX-Index jumped 0.42% to €792.48.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.08%.

Volatility

MKB Nedsense’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.20%, a negative 0.15%, and a positive 3.74%.

MKB Nedsense’s highest amplitude of average volatility was 5.46% (last week), 4.00% (last month), and 3.74% (last quarter).

More news about MKB Nedsense.

7. IEX GROUP NV (IEX.AS)

-7.61% Price Change

IEX Group N.V., through its subsidiaries, operates financial websites in the Netherlands and Belgium. It operates Beurs.nl, Belegger.nl, Beleggen.nl, DeBeurs.nl, Beursonline.nl, Participaties.nl, Beursgorilla.nl, Tostrams.nl and Guruwatch websites. The company also provides investment information services. In addition, the company offers IEX Expert and IEX Profs magazine for various investors; and organizes various events for private individuals and professionals. IEX Group N.V. was founded in 1999 and is based in Amsterdam, the Netherlands.

AEX-Index ended the session with IEX GROUP NV falling 7.61% to €1.70 on Tuesday, after three sequential sessions in a row of losses. AEX-Index rose 0.42% to €792.48, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, IEX GROUP NV has a trailing twelve months EPS of €0.25.

PE Ratio

IEX GROUP NV has a trailing twelve months price to earnings ratio of 6.8. Meaning, the purchaser of the share is investing €6.8 for every euro of annual earnings.

Moving Average

IEX GROUP NV’s value is under its 50-day moving average of €1.76 and below its 200-day moving average of €1.79.

Volatility

IEX GROUP NV’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.24%, a positive 1.19%, and a positive 6.02%.

IEX GROUP NV’s highest amplitude of average volatility was 5.37% (last week), 3.70% (last month), and 6.02% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IEX GROUP NV’s stock is considered to be overbought (>=80).

More news about IEX GROUP NV.

8. GLINTT (GLINT.LS)

-5.85% Price Change

Glintt – Global Intelligent Technologies, S.A. provides IT consulting services for banking, insurance, public administration, and utilities sectors in Portugal, Spain, and Angola. It operates through two segments: Health and Other Markets. The company engages in the sale of equipment, furniture, consumables, and robotics solutions; development of architectural projects; and design and conception of lay-out and image for pharmacies, training, equipment maintenance, and consultancy projects. It licenses proprietary software solutions for healthcare providers, such as clinics, hospitals, pharmacies, and other bodies of the ministry of health; and develops, implements, and maintains software services for the health sector. In addition, the company implements ERPs, integrates internet systems, and develops tailor-made applications services. Further, the company develops, implements, and integrates partner platforms with emphasis on the BPM, ERP, BI and mobility solutions; and integrates IT infrastructures, as well as support for networking, security, storage systems, and database management. Glintt – Global Intelligent Technologies, S.A. was incorporated in 1995 and is based in Sintra, Portugal. Glintt – Global Intelligent Technologies, S.A. operates as a subsidiary of Farminveste – Investimentos, Participações E Gestão S.A.

PSI ended the session with GLINTT dropping 5.85% to €0.35 on Tuesday while PSI dropped 0.3% to €6,365.20.

Earnings Per Share

As for profitability, GLINTT has a trailing twelve months EPS of €0.04.

PE Ratio

GLINTT has a trailing twelve months price to earnings ratio of 8.85. Meaning, the purchaser of the share is investing €8.85 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.84%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GLINTT’s stock is considered to be oversold (<=20).

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jun 23, 2023, the estimated forward annual dividend rate is 0.02 and the estimated forward annual dividend yield is 5.93%.

Moving Average

GLINTT’s value is way above its 50-day moving average of €0.28 and way higher than its 200-day moving average of €0.25.

More news about GLINTT.

9. CRCAM ILLE-VIL.CCI (CIV.PA)

-5.37% Price Change

Caisse régionale de Crédit Agricole Mutuel d'Ille-et-Vilaine Société coopérative provides banking services in France. It offers bank accounts and related services; bank cards; saving solutions; real estate investment solutions; insurance products, such as car and two-wheeler, personal, health and welfare, home, and borrower insurance, as well as life insurance products; real estate loans; and consumer credit comprising personal, auto, green vehicle, work, boating, student, and apprentice loans, as well as renewable credit. The company was founded in 1900 and is based in Saint-Jacques-de-la-Lande, France. Caisse régionale de Crédit Agricole Mutuel d'Ille-et-Vilaine Société coopérative operates as a subsidiary of Crédit Agricole S.A.

CAC 40 ended the session with CRCAM ILLE-VIL.CCI sliding 5.37% to €56.02 on Tuesday, after two sequential sessions in a row of losses. CAC 40 rose 0.08% to €7,574.67, following the last session’s downward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, CRCAM ILLE-VIL.CCI has a trailing twelve months EPS of €13.97.

PE Ratio

CRCAM ILLE-VIL.CCI has a trailing twelve months price to earnings ratio of 4.01. Meaning, the purchaser of the share is investing €4.01 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.95%.

More news about CRCAM ILLE-VIL.CCI.

10. FERMENTALG (FALG.PA)

-4.94% Price Change

Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; aquafeeds and pet foods; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.

CAC 40 ended the session with FERMENTALG falling 4.94% to €0.25 on Tuesday while CAC 40 rose 0.08% to €7,574.67.

Earnings Per Share

As for profitability, FERMENTALG has a trailing twelve months EPS of €-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.52%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 55.4%, now sitting on 4.75M for the twelve trailing months.

Moving Average

FERMENTALG’s value is way below its 50-day moving average of €0.50 and way below its 200-day moving average of €0.90.

More news about FERMENTALG.

Stay up to date with our winners and losers daily report